{"id":"glucocorticoid-gc","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Osteoporosis"},{"rate":null,"effect":"Immunosuppression/increased infection risk"},{"rate":null,"effect":"Cushingoid features"},{"rate":null,"effect":"Mood disturbances"},{"rate":null,"effect":"Gastrointestinal upset"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Glucocorticoids are steroid hormones that bind to intracellular glucocorticoid receptors, translocate to the nucleus, and alter transcription of pro-inflammatory genes. This results in decreased production of cytokines, chemokines, and adhesion molecules, leading to broad immunosuppression and anti-inflammatory effects across multiple cell types including T cells, B cells, macrophages, and neutrophils.","oneSentence":"Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene transcription.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:31:19.642Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis)"},{"name":"Allergic and asthmatic conditions"},{"name":"Adrenal insufficiency"},{"name":"Hematologic malignancies and lymphomas"}]},"trialDetails":[{"nctId":"NCT04322357","phase":"PHASE2","title":"Twice Weekly Steroids and Exercise as Therapy for DMD","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-07-30","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":21},{"nctId":"NCT05379634","phase":"PHASE2","title":"A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-07-05","conditions":"Myositis","enrollment":36},{"nctId":"NCT07245732","phase":"PHASE4","title":"Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Rheumatoid Arthritis (RA)","enrollment":220},{"nctId":"NCT04930094","phase":"PHASE3","title":"Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-10-06","conditions":"Giant Cell Arteritis (GCA)","enrollment":355},{"nctId":"NCT05799755","phase":"PHASE4","title":"Myositis Interstitial Lung Disease Nintedanib Trial","status":"COMPLETED","sponsor":"Rohit Aggarwal, MD","startDate":"2023-08-01","conditions":"Myositis Associated Interstitial Lund Disease (MA-ILD)","enrollment":49},{"nctId":"NCT02997605","phase":"PHASE4","title":"Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-01-31","conditions":"RheumatoId Arthritis","enrollment":102},{"nctId":"NCT07159906","phase":"PHASE1, PHASE2","title":"Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-09-08","conditions":"Diffuse Large B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma","enrollment":62},{"nctId":"NCT07152366","phase":"PHASE4","title":"Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.","status":"RECRUITING","sponsor":"Shanghai Changzheng Hospital","startDate":"2025-04-15","conditions":"Thyroid Associated Ophthalmopathies","enrollment":96},{"nctId":"NCT05714930","phase":"NA","title":"LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2023-12-12","conditions":"Systemic Lupus Erythematosus","enrollment":606},{"nctId":"NCT03126110","phase":"PHASE1, PHASE2","title":"Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies","status":"COMPLETED","sponsor":"Incyte Biosciences International Sàrl","startDate":"2017-04-25","conditions":"Advanced Malignancies, Metastatic Cancer","enrollment":145},{"nctId":"NCT03649061","phase":"PHASE4","title":"COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA","status":"COMPLETED","sponsor":"P. Verschueren","startDate":"2018-06-08","conditions":"Arthritis, Rheumatoid","enrollment":276},{"nctId":"NCT06957002","phase":"PHASE2","title":"Bosentan in the Treatment of Giant Cell Arteritis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Giant Cell Arteritis (GCA)","enrollment":40},{"nctId":"NCT04882072","phase":"PHASE3","title":"A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)","status":"TERMINATED","sponsor":"Janssen Pharmaceutical K.K.","startDate":"2021-09-15","conditions":"Takayasu Arteritis","enrollment":14},{"nctId":"NCT05479448","phase":"","title":"Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-03","conditions":"Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA)","enrollment":30},{"nctId":"NCT02378298","phase":"PHASE4","title":"Rituximab (RTX) Therapy in Patients With Active TAO","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2011-12","conditions":"Ophthalmopathy, Thyroid-Associated","enrollment":38},{"nctId":"NCT06468709","phase":"PHASE4","title":"A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2024-06-20","conditions":"Type 1 AIP","enrollment":86},{"nctId":"NCT03898154","phase":"PHASE4","title":"Perioperative Glucocorticoid Administration in the Treatment of Adult Distal Radius Fractures","status":"RECRUITING","sponsor":"C. Liam Dwyer","startDate":"2019-07-10","conditions":"Distal Radius Fracture","enrollment":200},{"nctId":"NCT04042220","phase":"","title":"Glucocorticoids, Immunotherapy and Radiosurgery for Brain Metastases","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2019-11-01","conditions":"Brain Metastases","enrollment":200},{"nctId":"NCT05667883","phase":"","title":"Prognostic Model of GC/CTX in the Treatment of MN","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2023-06","conditions":"Idiopathic Membranous Nephropathy","enrollment":50},{"nctId":"NCT05667896","phase":"","title":"Prognostic Model of GC/TAC in the Treatment of MN","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2023-06","conditions":"Idiopathic Membranous Nephropathy","enrollment":50},{"nctId":"NCT02842814","phase":"NA","title":"Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2016-10","conditions":"Systemic Lupus Erythematosus","enrollment":333},{"nctId":"NCT03895801","phase":"PHASE2","title":"Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.","status":"COMPLETED","sponsor":"InflaRx GmbH","startDate":"2019-04-03","conditions":"Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA)","enrollment":57},{"nctId":"NCT01524536","phase":"PHASE4","title":"Steroid Treatment for Hypereosinophilic Syndrome","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-02-16","conditions":"Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder","enrollment":26},{"nctId":"NCT04124861","phase":"NA","title":"Withdraw Drug in Stable IgG4-Related Disease","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-06-23","conditions":"Autoimmune Diseases","enrollment":138},{"nctId":"NCT03492255","phase":"NA","title":"CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid","status":"TERMINATED","sponsor":"University of Sao Paulo General Hospital","startDate":"2018-04-12","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":49},{"nctId":"NCT04710849","phase":"","title":"Relationship Between Plasma Metabolome and the Efficacy of Systemic Glucocorticoid in AECOPD","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-02-01","conditions":"COPD, COPD Exacerbation Acute","enrollment":100},{"nctId":"NCT04569890","phase":"NA","title":"Treatment of Pregnancy RA","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2020-12-01","conditions":"Rheumatoid Arthritis, Pregnancy Related","enrollment":100},{"nctId":"NCT04034199","phase":"PHASE3","title":"Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid","status":"UNKNOWN","sponsor":"Kwong Wah Hospital","startDate":"2019-08-15","conditions":"Idiopathic Inflammatory Myopathies, Osteoporosis, Osteopenia","enrollment":40},{"nctId":"NCT03313297","phase":"PHASE2","title":"Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2018-04-10","conditions":"Diabetes Mellitus, Type 2","enrollment":28},{"nctId":"NCT03804723","phase":"NA","title":"Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus","status":"UNKNOWN","sponsor":"University of Pisa","startDate":"2019-06","conditions":"Systemic Lupus Erythematosus, Glucocorticoids, Therapy Withdrawal","enrollment":321},{"nctId":"NCT01411046","phase":"","title":"Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2011-04","conditions":"Rheumatoid Arthritis","enrollment":106},{"nctId":"NCT02265328","phase":"PHASE2","title":"Efficacy of Combination Therapy of Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic Hepatitis.","status":"COMPLETED","sponsor":"Dayanand Medical College and Hospital","startDate":"2014-09","conditions":"Severe Alcoholic Hepatitis in 'Extremis'- Defined by mDF>54","enrollment":25},{"nctId":"NCT02523300","phase":"NA","title":"Glucocorticoid on the Prognosis of TEVAR","status":"UNKNOWN","sponsor":"Changhai Hospital","startDate":"2015-10","conditions":"Aortic Dissection","enrollment":240},{"nctId":"NCT02190994","phase":"PHASE4","title":"Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2013-08","conditions":"Pituitary Neoplasms, Craniopharyngiomas","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2720,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Prednisone"],"phase":"marketed","status":"active","brandName":"Glucocorticoid (GC)","genericName":"Glucocorticoid (GC)","companyName":"First Affiliated Hospital of Zhejiang University","companyId":"first-affiliated-hospital-of-zhejiang-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene transcription. Used for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic and asthmatic conditions, Adrenal insufficiency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}